[Effect of endoscopical administration of OK-432 in 4 patients with advanced esophageal or gastric cancer].
OK-432 has been injected endoscopically into 4 patients with an unresectable esophageal or gastric cancer. Three months after the initial injection, a remarkable improvement in the symptoms and a reduction of the tumor size was recognized in all 4 patients. This study indicates that an OK-432 injection provides considerable benefits to patients with an advanced esophageal or gastric cancer.
Satomi
T
T
Dept. of Int. Med., Kochi Municipal Hospital.
Inoue
S
S
Fujita
T
T
Ogawa
S
S
Honda
H
H
Hayashi
M
M
D000230:Adenocarcinoma / Q000628:therapy; D002288:Adenocarcinoma, Mucinous / Q000628:therapy; D000368:Aged; D000369:Aged, 80 and over; D001688:Biological Products / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000628:therapy*; D004945:Esophagoscopy; D005773:Gastroscopy; D006801:Humans; D007267:Injections / Q000379:methods; D008297:Male; D008875:Middle Aged; D010844:Picibanil / Q000008:administration & dosage / Q000627:therapeutic use*; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000628:therapy*
D001688:Biological Products; D010844:Picibanil